PSP Research »

Nuvalent Inc-a shares owned by PSP Research

Quarter-by-quarter ownership of Nuvalent Inc-a (NUVL) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Nuvalent Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Nuvalent Inc-a held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvalent Inc-a by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $529k 5.3k 100.59

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Nuvalent Inc-a

Deerfield Management Company
FMR
Paradigm Biocapital Advisors
Vanguard Group
BlackRock
Wellington Management Company
Henderson Group
State Street Corporation
Jpmorgan Chase & Co
Perceptive Advisors
Polar Capital Holdings
T. Rowe Price Investment Management
RA Capital Management
Geode Capital Management
Bellevue Group

View all funds holding Nuvalent Inc-a